
Israeli drug firm CureTech is be sold for the third time in four years, this time to InSight Innovations in …

CureTech, a biotech firm owned by Clal Biotechnology Industries, is set to reclaim a drug it sold more than two …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader

